Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience.
Journal of hepatocellular carcinoma（2023）
摘要
Triple combination therapy resulted in a relatively high ORR and conversion resection rate following uHCC treatment.
更多查看译文
关键词
TACE, immune checkpoint inhibitors, tyrosine kinase inhibitor, surgical resection
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要